Severity of alcohol dependence is associated with the fatty acid amide hydrolase Pro129Thr missense variant

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Addiction Biology

• Publication date

  2018-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/adb.12491PMID 28150397PMCID PMC5538894
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• FAAH Gene Variation Moderates Stress Response and Symptom Severity in Patients with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence.

  2016cited by this paper
• Endocannabinoid Modulation of Orbitostriatal Circuits Gates Habit Formation.

  2016cited by this paper
• Involvement of Endocannabinoids in Alcohol "Binge" Drinking: Studies of Mice with Human Fatty Acid Amide Hydrolase Genetic Variation and After CB1 Receptor Antagonists.

  2016cited by this paper
• FAAH genetic variation enhances fronto-amygdala function in mouse and human

  2015cited by this paper
• Alcohol Dependence Genetics: Lessons Learned From Genome-Wide Association Studies (GWAS) and Post-GWAS Analyses.

  2015influential reference
• Endocannabinoid signaling in reward and addiction

  2015cited by this paper
• Risky alcohol consumption in young people is associated with the fatty acid amide hydrolase gene polymorphism C385A and affective rating of drug pictures

  2014cited by this paper
• Genome-wide association study of alcohol dependence:significant findings in African- and European-Americans including novel risk loci

  2014cited by this paper
• Power failure: why small sample size undermines the reliability of neuroscience

  2013cited by this paper
• Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity

  2013cited by this paper
• FAAH selectively influences placebo effects

  2013cited by this paper
• Latest advances in the discovery of fatty acid amide hydrolase inhibitors

  2013cited by this paper
• DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS, FIFTH EDITION

  2013cited by this paper
• Strong association of the alcohol dehydrogenase 1B gene (ADH1B) with alcohol dependence and alcohol-induced medical diseases.

  2011cited by this paper
• ADH1B is associated with alcohol dependence and alcohol consumption in populations of European and African ancestry

  2011cited by this paper
• CB1 receptor blockade decreases ethanol intake and associated neurochemical changes in fawn-hooded rats.

  2010cited by this paper
• A map of human genome variation from population-scale sequencing

  2010influential reference
• Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function.

  2009cited by this paper
• Addictions biology: haplotype-based analysis for 130 candidate genes on a single array.

  2008cited by this paper
• Manipulation of fatty acid amide hydrolase functional activity alters sensitivity and dependence to ethanol

  2007cited by this paper
• The alcohol use disorders identification test: an update of research findings.

  2007cited by this paper
• Genetic Impairment of Frontocortical Endocannabinoid Degradation and High Alcohol Preference

  2007cited by this paper
• Association study between alcoholism and endocannabinoid metabolic enzyme genes encoding fatty acid amide hydrolase and monoglyceride lipase in a Japanese population

  2007cited by this paper
• Role of Endocannabinoids in Alcohol Consumption and Intoxication: Studies of Mice Lacking Fatty Acid Amide Hydrolase

  2007cited by this paper
• Spurious genetic associations.

  2007cited by this paper
• The fatty acid amide hydrolase C385A (P129T) missense variant in cannabis users: Studies of drug use and dependence in caucasians

  2007cited by this paper
• Effect of chronic ethanol exposure and its withdrawal on the endocannabinoid system.

  2006cited by this paper
• Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats

  2006cited by this paper
• The fatty acid amide hydrolase 385 A/A (P129T) variant: haplotype analysis of an ancient missense mutation and validation of risk for drug addiction

  2006cited by this paper
• A nonsynonymous polymorphism in the human fatty acid amide hydrolase gene did not associate with either methamphetamine dependence or schizophrenia.

  2005cited by this paper
• Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use.

  2004cited by this paper
• Modulation of anxiety through blockade of anandamide hydrolysis

  2003cited by this paper
• Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice

  2003cited by this paper
• Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol‐induced dopamine release in the nucleus accumbens

  2003cited by this paper
• Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neurons.

  2003cited by this paper
• Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats

  2002cited by this paper
• Postsynaptic endocannabinoid release is critical to long-term depression in the striatum

  2002cited by this paper
• A missense mutation in human fatty acid amide hydrolase associated with problem drug use

  2002cited by this paper
• Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

  2001cited by this paper
• Replication validity of genetic association studies

  2001cited by this paper
• Inter-rater reliability of the SCID alcohol and substance use disorders section among adolescents.

  2000cited by this paper
• Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist.

  1999cited by this paper
• Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR-141716.

  1998cited by this paper
• Structured Clinical Interview for DSM-IV Axis I Disorders

  1997cited by this paper
• Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors

  1997cited by this paper
• A second endogenous cannabinoid that modulates long-term potentiation

  1997cited by this paper
• Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

  1996cited by this paper
• The reliability of the Alcohol Timeline Followback when administered by telephone and by computer.

  1996cited by this paper
• Controlling the false discovery rate: a practical and powerful approach to multiple testing

  1995influential reference
• Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II.

  1993cited by this paper
• Isolation and structure of a brain constituent that binds to the cannabinoid receptor.

  1992cited by this paper
• The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

  1991cited by this paper
• Structure of a cannabinoid receptor and functional expression of the cloned cDNA

  1990cited by this paper

• Ancestry-Specific Hypothetical Genetic Feedback About Lung Cancer Risk in African American Individuals Who Smoke: Cognitive, Emotional, and Motivational Effects on Cessation

  2025cites this paper
• Effects of acute alcohol administration on endocannabinoids and relation to subjective effects

  2025influential citation
• Cannabinoid-based Pharmacology for the Management of Substance Use Disorders.

  2025cites this paper
• FAAH and MAGL inhibition: Evolving approaches to treating substance use disorders.

  2025cites this paper
• Peripheral endocannabinoids in major depressive disorder and alcohol use disorder: a systematic review

  2024cites this paper
• FAAH rs324420 Polymorphism: Biological Pathways, Impact on Elite Athletic Performance and Insights for Sport Medicine

  2023cites this paper
• Functional Variation in the FAAH Gene Is Directly Associated with Subjective Well-Being and Indirectly Associated with Problematic Alcohol Use

  2023cites this paper
• Fatty Acid Amide Hydrolase, Neurodevelopment, and Alcohol: Illuminating the Intricacies of the Endocannabinoid System in Addiction Susceptibility.

  2023cites this paper
• Development and molecular modeling studies of new thiadiazole piperazine urea derivatives as potential fatty acid amide hydrolase inhibitors

  2022cites this paper
• Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition

  2022cites this paper
• Biomarkers of the Endocannabinoid System in Substance Use Disorders

  2022influential citation
• Association Between Fatty Acid Amide Hydrolase and Alcohol Response Phenotypes: A Positron Emission Tomography Imaging Study With [11C]CURB in Heavy-Drinking Youth.

  2022cites this paper
• Genetic variation in fatty acid amide hydrolase (FAAH): Associations with early drinking and smoking behaviors.

  2022cites this paper
• Fatty acid amide hydrolase C385A polymorphism affects susceptibility to various diseases

  2022cites this paper
• Association of Alcohol Use Disorder Risk With ADH1B, DRD2, FAAH, SLC39A8, GCKR, and PDYN Genetic Polymorphisms

  2022cites this paper
• The effects of acute alcohol administration on circulating endocannabinoid levels in humans

  2022cites this paper
• Fatty Acid Amide Hydrolase: An Integrative Clinical Perspective

  2022cites this paper
• Alcohol-Endocannabinoid Interactions: Implications for Addiction-Related Behavioral Processes

  2022cites this paper
• Endocannabinoid Gene × Gene Interaction Association to Alcohol Use Disorder in Two Adolescent Cohorts

  2021cites this paper
• Association of the Fatty Acid Amide Hydrolase C385A Polymorphism with Alcohol Use Severity and Coping Motives in Heavy-drinking Youth.

  2021cites this paper
• Association of Serotonin Transporter (SERT) Polymorphisms with Opioid Dependence and Dimensional Aspects of Cocaine Use in a Caucasian Cohort of Opioid Users

  2021cites this paper
• Contribution of Fatty Acid Amide Hydrolase to Alcohol Use Disorder: A Systematic Review

  2021cites this paper
• Association of FAAH p.Pro129Thr and COMT p.Ala72Ser with schizophrenia and comorbid substance use through next-generation sequencing: an exploratory analysis

  2021cites this paper
• FAAH and CNR1 Polymorphisms in the Endocannabinoid System and Alcohol-Related Sleep Quality

  2021cites this paper
• Analyses of polymorphisms of intron 2 of OPRK1 (kappa-opioid receptor gene) in association with opioid and cocaine dependence diagnoses in an African-American population.

  2021cites this paper
• NDT_A_286536 659..670

  2021cites this paper
• Endocannabinoid-Like Lipid Neuromodulators in the Regulation of Dopamine Signaling: Relevance for Drug Addiction

  2020cites this paper
• Lower brain fatty acid amide hydrolase in treatment-seeking patients with alcohol use disorder: a positron emission tomography study with [C-11]CURB

  2020cites this paper
• High genes: Genetic underpinnings of cannabis use phenotypes.

  2020cites this paper
• Neuropsychosocial Markers of Binge Drinking in Young Adults

  2020cites this paper
• Silencing synaptic MicroRNA‐411 reduces voluntary alcohol consumption in mice

  2019cites this paper
• Distinct functions of endogenous cannabinoid system in alcohol abuse disorders

  2019cites this paper
• CNR1 and FAAH variation and affective states induced by marijuana smoking

  2019cites this paper
• The Effectiveness of Gemfibrozil on Nicotine Dependence, Smoking Cessation, and its Symptom Among Smokers: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

  2019cites this paper
• A perspective review on fatty acid amide hydrolase (FAAH) inhibitors as potential therapeutic agents.

  2019cites this paper
• FAAH levels and its genetic polymorphism association with susceptibility to methamphetamine dependence

  2019cites this paper
• Endocannabinoids and Fear-Related Behavior in Mice Selectively Bred for High or Low Alcohol Preference

  2019influential citation
• Gender-specific association of functional prodynorphin 68 bp repeats with cannabis exposure in an African American cohort

  2018cites this paper
• Involvement of Activated Brain Stress Responsive Systems in Excessive and “Relapse” Alcohol Drinking in Rodent Models: Implications for Therapeutics

  2018cites this paper
• Ethanol‐induced alterations in endocannabinoids and relevant neurotransmitters in the nucleus accumbens of fatty acid amide hydrolase knockout mice

  2018cites this paper
• PPAR&agr;/CB1 receptor dual ligands as a novel therapy for alcohol use disorder: Evaluation of a novel oleic acid conjugate in preclinical rat models

  2018cites this paper
• Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies

  2018cites this paper
• Re-evaluation of the KMSK scales, rapid dimensional measures of self-exposure to specific drugs: Gender-specific features.

  2018cites this paper
• Brain activity of anandamide: a rewarding bliss?

  2018cites this paper
• Non-medical Cannabis Self-Exposure as a Dimensional Predictor of Opioid Dependence Diagnosis: A Propensity Score Matched Analysis

  2018cites this paper
• Blockade of alcohol escalation and “relapse” drinking by pharmacological FAAH inhibition in male and female C57BL/6J mice

  2017cites this paper
• The endocannabinoid system as a target for addiction treatment: Trials and tribulations

  2017cites this paper